China’s Cancer Market Is Evolving Fast, Four Multinationals Dominate
Executive Summary
In the Chinese pharmaceutical market, sales of anti-tumor drugs have been showing a steady growth trend in recent years as cancer patient numbers continue to rise.
You may also be interested in...
China: Value-Based Procurement Reshapes Strategies Of Multinational Medtech Firms
China’s growing market for medtech, estimated at $70bn in 2021, could more than double this decade if the government’s Healthy China 2030 plan stays on track.
China: Value-Based Procurement Reshapes Strategies Of Multinational Medtech Firms
China’s growing market for medtech, estimated at $70bn in 2021, could more than double this decade if the government’s Healthy China 2030 plan stays on track.
Asian Giants Are Racing For Neuroscience Developments
China, Japan and South Korea are the top economic powerhouses of Asia. They compete not only for production industries such as electronics, but also for medical sciences. China has enormous resources compared with the two other nations.